Ocular Therapeutix, Inc.
(NASDAQ : OCUL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.57%18.361.8%$100.01m
UTHRUnited Therapeutics Corporation
1.56%79.4514.3%$76.94m
SAGESAGE Therapeutics, Inc.
2.40%178.448.7%$76.05m
JAZZJazz Pharmaceuticals Plc
-2.22%127.532.3%$59.38m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.74%169.626.2%$56.06m
MDCOMedicines Company
1.25%35.7221.8%$53.07m
ICPTIntercept Pharmaceuticals, Inc.
2.59%81.5818.6%$48.16m
PRGOPerrigo Co. Plc
0.93%43.586.8%$47.99m
CTLTCatalent Inc
1.60%50.492.4%$37.93m
MNKMallinckrodt Plc
-1.08%9.1821.0%$37.63m
HZNPHorizon Pharma plc
3.33%23.576.7%$35.55m
ARQLArQule, Inc.
16.71%9.570.7%$35.50m
ICLRICON Plc
0.62%143.804.1%$34.52m
ZYNEZynerba Pharmaceuticals Inc
0.31%13.078.3%$32.36m
AXSMAxsome Therapeutics, Inc.
-0.83%22.642.1%$28.37m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.